Literature DB >> 1352274

Structural gene aberrations in mucopolysaccharidosis II (Hunter).

M Wehnert1, J J Hopwood, W Schröder, F H Herrmann.   

Abstract

A total of 14 unrelated German patients with X-linked iduronate-2-sulfatase (IDS) deficiency (Hunter syndrome, MPS II) showing variable clinical manifestations was screened for structural gene aberrations by Southern analysis. Using the IDS cDNA clone c2S15 as a probe, no Southern fragments could be detected in blots in the severely affected patient G-65 with respect to DNA digested by HindIII, PstI and TaqI, suggesting a total loss of the IDS structural gene. In this patient, the flanking loci DXS 297, DXS 296 and DXS 466 were tested. The locus DXS 466 is involved in the deletion, whereas both of the other loci are present. A normal 9.0-kb fragment disappeared and an aberrant fragment of 3.5 kb occurred in the HindIII blot of patient G-117. A normal Southern pattern was found in PstI and TaqI blots of this patient. This result can be interpreted as the generation of an additional HindIII restriction site by point mutation in an IDS gene intron.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352274     DOI: 10.1007/bf00194316

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  11 in total

1.  Haemophilia B: database of point mutations and short additions and deletions--second edition.

Authors:  F Giannelli; P M Green; K A High; S Sommer; D P Lillicrap; M Ludwig; K Olek; P H Reitsma; M Goossens; A Yoshioka
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

2.  Characterization of three new deletions at the 5' end of the HPRT structural gene.

Authors:  M Wehnert; F H Herrmann
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  New distal marker closely linked to the fragile X locus.

Authors:  T J Hulsebos; B A Oostra; S Broersen; A Smits; B A van Oost; A Westerveld
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

4.  A BclI RFLP for DXS296 (VK21) near the fragile X.

Authors:  S Yu; G K Suthers; J C Mulley
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

5.  [Prenatal biochemical diagnosis in genetically-induced metabolic diseases].

Authors:  G Machill; G Seidlitz; U Grimm; M Zschiesche; L Petruschka; M Wehnert; W Knoll; M Schütz; A Knapp; F H Herrmann
Journal:  Z Arztl Fortbild (Jena)       Date:  1988

6.  Genetic mapping of new RFLPs at Xq27-q28.

Authors:  G K Suthers; I Oberlé; J Nancarrow; J C Mulley; V J Hyland; P J Wilson; J McCure; C P Morris; J J Hopwood; J L Mandel
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

7.  Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA.

Authors:  P J Wilson; C P Morris; D S Anson; T Occhiodoro; J Bielicki; P R Clements; J J Hopwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

8.  The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome).

Authors:  J E Wraith; A Cooper; M Thornley; P J Wilson; P V Nelson; C P Morris; J J Hopwood
Journal:  Hum Genet       Date:  1991-06       Impact factor: 4.132

9.  Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome.

Authors:  P J Wilson; G K Suthers; D F Callen; E Baker; P V Nelson; A Cooper; J E Wraith; G R Sutherland; C P Morris; J J Hopwood
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

10.  Human X chromosome markers and Duchenne muscular dystrophy.

Authors:  K E Davies; A Speer; F Herrmann; A W Spiegler; S McGlade; M H Hofker; P Briand; R Hanke; M Schwartz; V Steinbicker
Journal:  Nucleic Acids Res       Date:  1985-05-24       Impact factor: 16.971

View more
  5 in total

1.  Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.

Authors:  C Steglich; S Bunge; T Hulsebos; M Beck; N J Brandt; E Schwinger; J J Hopwood; A Gal
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

2.  Heterogeneity of DNA and RNA in Hunter patients.

Authors:  T Annella; A Daniele; P Di Natale
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

3.  Carrier detection of Hunter syndrome (MPS II) by biochemical and DNA techniques in families at risk.

Authors:  W Schröder; L Petruschka; M Wehnert; M Zschiesche; G Seidlitz; J J Hopwood; F H Herrmann
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

4.  Mucopolysaccharidosis type II (Hunter syndrome): characterization of the iduronate-2-sulphatase in MPS II skin fibroblasts.

Authors:  L Petruschka; M Zschiesche; J Bielicki; G Seidlitz; G Machill; J J Hopwood; F H Herrmann
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.

Authors:  J J Jonsson; E L Aronovich; S E Braun; C B Whitley
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.